A detailed history of Optimas Capital LTD transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Optimas Capital LTD holds 62,900 shares of BMY stock, worth $3.54 Million. This represents 3.09% of its overall portfolio holdings.

Number of Shares
62,900
Holding current value
$3.54 Million
% of portfolio
3.09%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$39.66 - $51.75 $2.49 Million - $3.26 Million
62,900 New
62,900 $3.26 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Optimas Capital LTD Portfolio

Follow Optimas Capital LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Optimas Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Optimas Capital LTD with notifications on news.